Literature DB >> 11740368

Laparoscopic anterior lumbar interbody fusion with rhBMP-2: a prospective study of clinical and radiographic outcomes.

T J Kleeman1, U M Ahn, A Talbot-Kleeman.   

Abstract

STUDY
DESIGN: To prospectively evaluate the clinical and radiographic outcome of laparoscopic anterior lumbar interbody fusion with rhBMP-2.
OBJECTIVES: It was hypothesized that discogenic pain could be treated successfully with an anterior lumbar interbody fusion performed laparoscopically using rhBMP-2 as a replacement for autogenous bone. SUMMARY OF BACKGROUND DATA: The traditional surgical treatment of discogenic pain involves painful incisions of muscles, with potential loss of integrity and strength. Harvesting of bone graft is associated with significant complications including persistent pain at the donor site.
METHODS: Twenty-two consecutive patients were studied prospectively with the surgery performed by one surgeon. Patients were evaluated clinically and radiographically at 6 and 12 months after surgery. An unbiased radiologist read postoperative computed tomography scans for evidence of fusion.
RESULTS: There were 8 male (36%) and 14 female (64%) patients. The average age was 38 years (range, 21-56 years). At 6 and 12 months after surgery 95% (21 of 22) were available for follow-up; 100% were satisfied with treatment at 12 months. Concerning their symptoms, 100% reported relief of back pain, 100% had improvement of leg pain, and 100% described significant functional improvement. Improvements were seen at 6 and 12 months on Oswestry (P < 0.001), functional testing (P < 0.001), and pain analog scale (P < 0.001). Radiographic analysis showed that all of the patients had evidence of a solid fusion at 6 months after operation.
CONCLUSION: Discogenic low back pain can be effectively treated surgically with a laparoscopic anterior lumbar interbody fusion using rhBMP-2 in place of autogenous bone. The fusion occurs quickly and predictably with no adverse effects identified.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11740368     DOI: 10.1097/00007632-200112150-00026

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  12 in total

1.  Sexual function in men and women after anterior surgery for chronic low back pain.

Authors:  Olle Hägg; Peter Fritzell; Anders Nordwall
Journal:  Eur Spine J       Date:  2005-09-07       Impact factor: 3.134

2.  Bone substitutes and expanders in Spine Surgery: A review of their fusion efficacies.

Authors:  Abhijeet Kadam; Paul W Millhouse; Christopher K Kepler; Kris E Radcliff; Michael G Fehlings; Michael E Janssen; Rick C Sasso; James J Benedict; Alexander R Vaccaro
Journal:  Int J Spine Surg       Date:  2016-09-22

Review 3.  The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.

Authors:  Slobodan Vukicevic; Hermann Oppermann; Donatella Verbanac; Morana Jankolija; Irena Popek; Jasna Curak; Jelena Brkljacic; Martina Pauk; Igor Erjavec; Igor Francetic; Ivo Dumic-Cule; Mislav Jelic; Dragan Durdevic; Tomislav Vlahovic; Ruder Novak; Vera Kufner; Tatjana Bordukalo Niksic; Marija Kozlovic; Zrinka Banic Tomisic; Jadranka Bubic-Spoljar; Ivancica Bastalic; Smiljka Vikic-Topic; Mihaela Peric; Marko Pecina; Lovorka Grgurevic
Journal:  Int Orthop       Date:  2013-12-19       Impact factor: 3.075

Review 4.  Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.

Authors:  Antonio Faundez; Clément Tournier; Matthieu Garcia; Stéphane Aunoble; Jean-Charles Le Huec
Journal:  Int Orthop       Date:  2016-03-10       Impact factor: 3.075

5.  Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.

Authors:  Rahul Vaidya; Julia Carp; Anil Sethi; Stephen Bartol; Joseph Craig; Clifford M Les
Journal:  Eur Spine J       Date:  2007-03-27       Impact factor: 3.134

6.  Effectiveness and Feasibility of Injectable Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 for Anterior Lumbar Interbody Fusion at the Lumbosacral Junction in Adult Spinal Deformity Surgery: A Clinical Pilot Study.

Authors:  Sang-Kyu Im; Jung-Hee Lee; Ki Young Lee; Seung-Jin Yoo
Journal:  Orthop Surg       Date:  2022-05-27       Impact factor: 2.279

7.  A two-cage reconstruction versus a single mega-cage reconstruction for lumbar interbody fusion: an experimental comparison.

Authors:  Hideki Murakami; William C Horton; Katsuro Tomita; William C Hutton
Journal:  Eur Spine J       Date:  2004-03-27       Impact factor: 3.134

8.  Pain and disability after first-time spinal fusion for lumbar degenerative disorders: a systematic review and meta-analysis.

Authors:  Niek Koenders; Alison Rushton; Martin L Verra; Paul C Willems; Thomas J Hoogeboom; J Bart Staal
Journal:  Eur Spine J       Date:  2018-07-11       Impact factor: 3.134

9.  Recombinant human bone morphogenetic protein 2 labeled use in spinal surgery and sexual dysfunction.

Authors:  Marija Rakovac; Ivan Bojanic; Tomislav Smoljanovic
Journal:  Surg Neurol Int       Date:  2011-04-28

10.  L5-S1 laparoscopic anterior interbody fusion.

Authors:  Constantine T Frantzides; Tallal M Zeni; Frank M Phillips; Sameer Mathur; John G Zografakis; Ronald M Moore; Luis E Laguna
Journal:  JSLS       Date:  2006 Oct-Dec       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.